CSTL logo

Castle Biosciences (CSTL) Company Overview

Profile

Full Name:

Castle Biosciences, Inc.

Sector:

Healthcare

Country:

United States

IPO:

July 25, 2019

Indexes:

Not included

Description:

Castle Biosciences, Inc. is a company focused on treating dermatologic cancers at the commercial stage. The company is dedicated to providing physicians and their patients with personalized, clinically meaningful genomic information to make more accurate treatment decisions. The company has two patented products on the market, DecisionDx-Melanoma and DecisionDx-UM, as well as two active proprietary products in development: DecisionDx-UM and DecisionDx-Melanoma. The company develops treatment plans for certain types of cancer taking into account clinical and pathological factors. Its flagship product, DecisionDx-Melanoma, is a patented gene expression profile (GEP) test that predicts the risk of metastasis or recurrence in patients diagnosed with invasive cutaneous melanoma, a deadly skin cancer. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Key Details

Price

$21.54

Annual Revenue

$332.07 M(+51.09% YoY)

Annual EPS

$0.62(+128.97% YoY)

Beta

0.93

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 28, 25 Baird
Outperform
Jan 2, 25 Stephens & Co.
Overweight
Nov 6, 24 Scotiabank
Sector Outperform
Nov 5, 24 Lake Street
Buy
Nov 5, 24 Keybanc
Overweight
Nov 5, 24 Baird
Outperform
Oct 29, 24 Canaccord Genuity
Buy
Oct 14, 24 BTIG
Buy
Aug 6, 24 Stephens & Co.
Overweight
Aug 6, 24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Castle Biosciences?
  • Does Castle Biosciences pay dividends?
  • What sector is Castle Biosciences in?
  • What industry is Castle Biosciences in?
  • What country is Castle Biosciences based in?
  • When did Castle Biosciences go public?
  • Is Castle Biosciences in the S&P 500?
  • Is Castle Biosciences in the NASDAQ 100?
  • Is Castle Biosciences in the Dow Jones?
  • When was Castle Biosciences's last earnings report?
  • When does Castle Biosciences report earnings?
  • Should I buy Castle Biosciences stock now?

What is the ticker symbol for Castle Biosciences?

The ticker symbol for Castle Biosciences is NASDAQ:CSTL

Does Castle Biosciences pay dividends?

No, Castle Biosciences does not pay dividends

What sector is Castle Biosciences in?

Castle Biosciences is in the Healthcare sector

What industry is Castle Biosciences in?

Castle Biosciences is in the Diagnostics & Research industry

What country is Castle Biosciences based in?

Castle Biosciences is headquartered in United States

When did Castle Biosciences go public?

Castle Biosciences's initial public offering (IPO) was on July 25, 2019

Is Castle Biosciences in the S&P 500?

No, Castle Biosciences is not included in the S&P 500 index

Is Castle Biosciences in the NASDAQ 100?

No, Castle Biosciences is not included in the NASDAQ 100 index

Is Castle Biosciences in the Dow Jones?

No, Castle Biosciences is not included in the Dow Jones index

When was Castle Biosciences's last earnings report?

Castle Biosciences's most recent earnings report was on Feb 27, 2025

When does Castle Biosciences report earnings?

The next expected earnings date for Castle Biosciences is May 2, 2025

Should I buy Castle Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions